Moreover, only CIP-m cells were found sensititve to treatments with SET-PP2A targeting drugs, such as FTY720, which rescued PP2A activity, blocking cell proliferation at metastatic level [112]. This evidence concerns the gene PTPA and hereditary sensory and autonomic neuropathy.